Renaissance Pharma inks partnership with St. Jude Children’s Research Hospital for neuroblastoma treatment
Renaissance Pharma, a company focused on the development of life changing therapies in pediatric rare disease, has entered into an exclusive license agreement with St. Jude Children’s Research Hospital for Hu14.18, a humanised antibody in development by...
